Women's Pain Study
Take part in a new research study for a potential new treatment option.
If you experience ongoing period or pelvic pain that’s hard to manage, you’re not alone and research is underway to help.
We’re inviting women who experience persistent or severe menstrual and/or pelvic pain to take part in a new clinical research study. The study aims to explore a potential new treatment option designed to improve quality of life for those living with these symptoms.
Critical Eligibility Criteria:
To take part in this study, you will need to meet all the following:
- 18 to 45 years of age
- Experience menstrual pain
Please note, additional eligibility criteria will apply
Commitment:
Approximately 6 months
Locations:
South Australia
If you take part in this research study, there will be:
Reimbursement of costs
For out-of-pocket expenses, such as travel and parking.
Convenience
There are no overnight stays
Free study-related medical care
Be among the first to access potential new research treatments before they are widely available.
Expert medical monitoring
Receive top-tier medical care and monitoring from experienced healthcare professionals.
Contribution to medical research
Help investigate a potential new treatment that could improve the lives of individuals with vitiligo
Register your interest now
or scroll down to read the study FAQs
Study Guide
01
Who can take part in this study?
-
To take part, you must meet the following criteria (additional criteria apply):
- Aged between 18-45 years
- Experience menstrual pain
- Be willing to have an insertion of an intrauterine device
- Be willing to record your experience on a phone APP each day
02
Who is unable to take part in this study?
+
Unfortunately, you will not be able to participate if:
- You have used long-acting preparations containing sex hormones within 30 days prior to the screening visit.
- History of abnormal liver or kidney disease.
- Had a surgical procedure within the previous 30 days.
Additional exclusion criteria apply.
03
What does the study involve for participants?
+
If eligible, your participation is expected to last approximately 6 months, and you will need to attend up to 6 scheduled study visits at a clinical site.
Participation is voluntary, and you can withdraw from the study at any time.
04
What is the purpose of this study?
+
Alyra Biotech has developed a new intrauterine device (Alyra Device) to help people with difficult to manage period and pelvic pain. Professor Louise Hull and the great team of doctors and nurses at the PARC Research Centre, located within the Royal Adelaide Hospital, invite you to be part of this important trial. They will care for you throughout the study period, and you can withdraw from the trial at any time if the device doesn’t suit you.
The first trial of the Alyra Device was successfully undertaken at PARC in 2024, and we are now ready to invite a larger number of people to participate in our next trial.
05
What is Pelvic Period Pain?
+
Pelvic period pain refers to cramping or discomfort in the lower abdomen or pelvic area that occurs before or during menstruation.
06
Why is this study important?
+
This study is important because it aims to better understand and develop new treatment options for people experiencing persistent pelvic and period pain, which can significantly impact daily life, work, and wellbeing. Many individuals suffer for years without effective relief or a clear diagnosis, so research like this is vital to improve care and outcomes.
07
Who is sponsoring this study?
+
This study is being sponsored by Alyra Biotech.
08
Where is my nearest study site?
+
Here is a list of all of the sites who are currently recruiting for this study:
- PARC Clinical Research at the Royal Adelaide Hospital
09
What if I have other questions about the study?
+
We are here for you! Head to our Evrima Help Centre and search for answers relating to clinical trials, study information and managing your Evrilink account
This study has been approved by an independent Human Research Ethics Committee
Help make medical research breakthroughs happen.
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs